| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | kainate selective glutamate receptor activity | 1.15e-05 | 6 | 18 | 2 | GO:0015277 | |
| GeneOntologyMolecularFunction | extracellularly glutamate-gated ion channel activity | 1.61e-05 | 7 | 18 | 2 | GO:0005234 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 7.59e-05 | 93 | 18 | 3 | GO:0097110 | |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 1.04e-04 | 17 | 18 | 2 | GO:0004970 | |
| GeneOntologyMolecularFunction | ligand-gated sodium channel activity | 1.16e-04 | 18 | 18 | 2 | GO:0015280 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 2.09e-04 | 24 | 18 | 2 | GO:0099507 | |
| GeneOntologyMolecularFunction | peptidase activity | 2.23e-04 | 654 | 18 | 5 | GO:0008233 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 2.66e-04 | 27 | 18 | 2 | GO:0008066 | |
| GeneOntologyMolecularFunction | metallocarboxypeptidase activity | 3.51e-04 | 31 | 18 | 2 | GO:0004181 | |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 6.78e-04 | 43 | 18 | 2 | GO:0005231 | |
| GeneOntologyMolecularFunction | carboxypeptidase activity | 8.80e-04 | 49 | 18 | 2 | GO:0004180 | |
| GeneOntologyMolecularFunction | sodium channel activity | 9.91e-04 | 52 | 18 | 2 | GO:0005272 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 1.19e-03 | 57 | 18 | 2 | GO:1904315 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 1.32e-03 | 60 | 18 | 2 | GO:0099529 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 1.54e-03 | 65 | 18 | 2 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 1.54e-03 | 65 | 18 | 2 | GO:0022824 | |
| GeneOntologyMolecularFunction | metalloexopeptidase activity | 1.79e-03 | 70 | 18 | 2 | GO:0008235 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 2.05e-03 | 75 | 18 | 2 | GO:0098960 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 2.16e-03 | 77 | 18 | 2 | GO:0005230 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase activity | 2.68e-03 | 86 | 18 | 2 | GO:0004197 | |
| GeneOntologyMolecularFunction | gated channel activity | 3.14e-03 | 334 | 18 | 3 | GO:0022836 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 3.39e-03 | 343 | 18 | 3 | GO:0005261 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 3.61e-03 | 100 | 18 | 2 | GO:0030594 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 3.97e-03 | 105 | 18 | 2 | GO:0015171 | |
| GeneOntologyMolecularFunction | exopeptidase activity | 4.34e-03 | 110 | 18 | 2 | GO:0008238 | |
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | 4.66e-03 | 114 | 18 | 2 | GO:0004843 | |
| GeneOntologyMolecularFunction | PDZ domain binding | 5.40e-03 | 123 | 18 | 2 | GO:0030165 | |
| GeneOntologyMolecularFunction | deubiquitinase activity | 5.48e-03 | 124 | 18 | 2 | GO:0101005 | |
| GeneOntologyMolecularFunction | potassium channel activity | 5.83e-03 | 128 | 18 | 2 | GO:0005267 | |
| GeneOntologyMolecularFunction | calcium channel activity | 5.92e-03 | 129 | 18 | 2 | GO:0005262 | |
| GeneOntologyMolecularFunction | SNARE binding | 6.56e-03 | 136 | 18 | 2 | GO:0000149 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | 6.65e-03 | 137 | 18 | 2 | GO:0019783 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 6.94e-03 | 140 | 18 | 2 | GO:0099094 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 7.62e-03 | 459 | 18 | 3 | GO:0005216 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 7.89e-03 | 465 | 18 | 3 | GO:0046873 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 8.03e-03 | 151 | 18 | 2 | GO:0015085 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 9.74e-03 | 167 | 18 | 2 | GO:0015079 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.02e-02 | 171 | 18 | 2 | GO:0015081 | |
| GeneOntologyMolecularFunction | channel activity | 1.10e-02 | 525 | 18 | 3 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 1.10e-02 | 526 | 18 | 3 | GO:0022803 | |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | 1.27e-02 | 192 | 18 | 2 | GO:0008234 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.28e-02 | 193 | 18 | 2 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.34e-02 | 197 | 18 | 2 | GO:0022834 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 1.37e-02 | 200 | 18 | 2 | GO:0008237 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 1.47e-02 | 207 | 18 | 2 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 1.48e-02 | 208 | 18 | 2 | GO:0005342 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 1.77e-02 | 627 | 18 | 3 | GO:0022890 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 2.06e-02 | 664 | 18 | 3 | GO:0008324 | |
| GeneOntologyBiologicalProcess | negative regulation of synaptic transmission, glutamatergic | 5.58e-05 | 13 | 18 | 2 | GO:0051967 | |
| GeneOntologyCellularComponent | kainate selective glutamate receptor complex | 1.05e-05 | 6 | 18 | 2 | GO:0032983 | |
| GeneOntologyCellularComponent | sodium channel complex | 2.80e-04 | 29 | 18 | 2 | GO:0034706 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 5.05e-04 | 817 | 18 | 5 | GO:0098978 | |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 6.78e-04 | 45 | 18 | 2 | GO:0008328 | |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 8.37e-04 | 50 | 18 | 2 | GO:0098878 | |
| GeneOntologyCellularComponent | receptor complex | 1.32e-03 | 581 | 18 | 4 | GO:0043235 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 2.57e-03 | 88 | 18 | 2 | GO:0016529 | |
| GeneOntologyCellularComponent | terminal bouton | 3.04e-03 | 96 | 18 | 2 | GO:0043195 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 3.15e-03 | 350 | 18 | 3 | GO:0098802 | |
| GeneOntologyCellularComponent | potassium channel complex | 3.56e-03 | 104 | 18 | 2 | GO:0034705 | |
| GeneOntologyCellularComponent | sarcoplasm | 4.26e-03 | 114 | 18 | 2 | GO:0016528 | |
| MousePheno | decreased circulating protein level | 9.41e-06 | 698 | 17 | 7 | MP:0014502 | |
| MousePheno | abnormal spinal reflex | 2.58e-05 | 148 | 17 | 4 | MP:0012079 | |
| MousePheno | abnormal response to tactile stimuli | 2.58e-05 | 148 | 17 | 4 | MP:0005316 | |
| MousePheno | abnormal touch/ nociception | 6.50e-05 | 376 | 17 | 5 | MP:0001968 | |
| MousePheno | decreased circulating serum albumin level | 1.64e-04 | 238 | 17 | 4 | MP:0005419 | |
| MousePheno | decreased circulating enzyme level | 2.40e-04 | 263 | 17 | 4 | MP:0014451 | |
| MousePheno | decreased enzyme/conezyme level | 3.22e-04 | 284 | 17 | 4 | MP:0014449 | |
| MousePheno | increased adipocyte glucose uptake | 3.78e-04 | 24 | 17 | 2 | MP:0030016 | |
| Domain | PBPe | 1.18e-04 | 18 | 17 | 2 | SM00079 | |
| Domain | Zn_pept | 1.18e-04 | 18 | 17 | 2 | SM00631 | |
| Domain | Iono_rcpt_met | 1.18e-04 | 18 | 17 | 2 | IPR001508 | |
| Domain | Glu/Gly-bd | 1.18e-04 | 18 | 17 | 2 | IPR019594 | |
| Domain | Iontro_rcpt | 1.18e-04 | 18 | 17 | 2 | IPR001320 | |
| Domain | Lig_chan | 1.18e-04 | 18 | 17 | 2 | PF00060 | |
| Domain | Lig_chan-Glu_bd | 1.18e-04 | 18 | 17 | 2 | SM00918 | |
| Domain | Lig_chan-Glu_bd | 1.18e-04 | 18 | 17 | 2 | PF10613 | |
| Domain | CARBOXYPEPT_ZN_2 | 1.32e-04 | 19 | 17 | 2 | PS00133 | |
| Domain | CARBOXYPEPT_ZN_1 | 1.47e-04 | 20 | 17 | 2 | PS00132 | |
| Domain | Peptidase_M14 | 1.95e-04 | 23 | 17 | 2 | PF00246 | |
| Domain | Peptidase_M14 | 1.95e-04 | 23 | 17 | 2 | IPR000834 | |
| Domain | ANF_receptor | 5.10e-04 | 37 | 17 | 2 | PF01094 | |
| Domain | ANF_lig-bd_rcpt | 5.10e-04 | 37 | 17 | 2 | IPR001828 | |
| Domain | Peripla_BP_I | 5.66e-04 | 39 | 17 | 2 | IPR028082 | |
| Domain | USP_CS | 1.62e-03 | 66 | 17 | 2 | IPR018200 | |
| Domain | USP_1 | 1.82e-03 | 70 | 17 | 2 | PS00972 | |
| Domain | UCH | 1.87e-03 | 71 | 17 | 2 | PF00443 | |
| Domain | USP_2 | 1.87e-03 | 71 | 17 | 2 | PS00973 | |
| Domain | USP_dom | 1.92e-03 | 72 | 17 | 2 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 1.92e-03 | 72 | 17 | 2 | IPR001394 | |
| Domain | USP_3 | 1.92e-03 | 72 | 17 | 2 | PS50235 | |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | 4.10e-05 | 10 | 14 | 2 | M10272 | |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | 6.01e-05 | 12 | 14 | 2 | MM15142 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 3.92e-04 | 30 | 14 | 2 | M18193 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 4.47e-04 | 32 | 14 | 2 | MM15143 | |
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 12947409 | ||
| Pubmed | Assessing the role of GLUK5 and GLUK6 at hippocampal mossy fiber synapses. | 2.53e-07 | 2 | 18 | 2 | 15537878 | |
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 15673679 | ||
| Pubmed | Subunit composition of kainate receptors in hippocampal interneurons. | 2.53e-07 | 2 | 18 | 2 | 11144357 | |
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 25043179 | ||
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 11182092 | ||
| Pubmed | Kainate receptor-mediated synaptic transmission in the adult anterior cingulate cortex. | 2.53e-07 | 2 | 18 | 2 | 15928066 | |
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 15358807 | ||
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 14724198 | ||
| Pubmed | Q/R site editing in kainate receptor GluR5 and GluR6 pre-mRNAs requires distant intronic sequences. | 2.53e-07 | 2 | 18 | 2 | 8700852 | |
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 15539395 | ||
| Pubmed | Role of GluK1 kainate receptors in seizures, epileptic discharges, and epileptogenesis. | 2.53e-07 | 2 | 18 | 2 | 24760837 | |
| Pubmed | A mosaic of functional kainate receptors in hippocampal interneurons. | 2.53e-07 | 2 | 18 | 2 | 15483117 | |
| Pubmed | Functional characterization of kainate receptors in the mouse nucleus accumbens. | 2.53e-07 | 2 | 18 | 2 | 11985817 | |
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 7696618 | ||
| Pubmed | Q/R site editing controls kainate receptor inhibition by membrane fatty acids. | 2.53e-07 | 2 | 18 | 2 | 16221857 | |
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 16219388 | ||
| Pubmed | Expression and novel subunit isoforms of glutamate receptor genes GluR5 and GluR6. | 2.53e-07 | 2 | 18 | 2 | 8260617 | |
| Pubmed | Subunit composition and alternative splicing regulate membrane delivery of kainate receptors. | 2.53e-07 | 2 | 18 | 2 | 15014126 | |
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 11069933 | ||
| Pubmed | 7.59e-07 | 3 | 18 | 2 | 31513786 | ||
| Pubmed | 7.59e-07 | 3 | 18 | 2 | 15509753 | ||
| Pubmed | Differential trafficking of GluR7 kainate receptor subunit splice variants. | 7.59e-07 | 3 | 18 | 2 | 15805114 | |
| Pubmed | Distinct Subunit Domains Govern Synaptic Stability and Specificity of the Kainate Receptor. | 7.59e-07 | 3 | 18 | 2 | 27346345 | |
| Pubmed | 7.59e-07 | 3 | 18 | 2 | 1379666 | ||
| Pubmed | 7.59e-07 | 3 | 18 | 2 | 8730589 | ||
| Pubmed | RNA editing of the glutamate receptor subunits GluR2 and GluR6 in human brain tissue. | 7.59e-07 | 3 | 18 | 2 | 7523595 | |
| Pubmed | Kainate receptor-mediated responses in the CA1 field of wild-type and GluR6-deficient mice. | 7.59e-07 | 3 | 18 | 2 | 9880586 | |
| Pubmed | 1.52e-06 | 4 | 18 | 2 | 17650106 | ||
| Pubmed | 1.52e-06 | 4 | 18 | 2 | 26277340 | ||
| Pubmed | 1.52e-06 | 4 | 18 | 2 | 15513934 | ||
| Pubmed | Synaptic activation of kainate receptors gates presynaptic CB(1) signaling at GABAergic synapses. | 1.52e-06 | 4 | 18 | 2 | 20081851 | |
| Pubmed | Reduced synaptic function of Kainate receptors in the insular cortex of Fmr1 Knock-out mice. | 1.52e-06 | 4 | 18 | 2 | 30241548 | |
| Pubmed | 1.52e-06 | 4 | 18 | 2 | 16354929 | ||
| Pubmed | 1.52e-06 | 4 | 18 | 2 | 19369569 | ||
| Pubmed | 1.52e-06 | 4 | 18 | 2 | 25556835 | ||
| Pubmed | 1.52e-06 | 4 | 18 | 2 | 17174564 | ||
| Pubmed | Developmental expression patterns of kainate receptors in the mouse spinal cord. | 2.53e-06 | 5 | 18 | 2 | 23076118 | |
| Pubmed | Kainate receptors: pharmacology, function and therapeutic potential. | 2.53e-06 | 5 | 18 | 2 | 18793656 | |
| Pubmed | 2.53e-06 | 5 | 18 | 2 | 28228252 | ||
| Pubmed | 2.53e-06 | 5 | 18 | 2 | 12223554 | ||
| Pubmed | RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. | 2.53e-06 | 5 | 18 | 2 | 1717158 | |
| Pubmed | 2.53e-06 | 5 | 18 | 2 | 28854365 | ||
| Pubmed | 2.53e-06 | 5 | 18 | 2 | 18358623 | ||
| Pubmed | Development of laminar distributions of kainate receptors in the somatosensory cortex of mice. | 2.53e-06 | 5 | 18 | 2 | 9593973 | |
| Pubmed | Preferential assembly of heteromeric kainate and AMPA receptor amino terminal domains. | 2.53e-06 | 5 | 18 | 2 | 29058671 | |
| Pubmed | 3.79e-06 | 6 | 18 | 2 | 12597860 | ||
| Pubmed | N-glycan content modulates kainate receptor functional properties. | 3.79e-06 | 6 | 18 | 2 | 28714086 | |
| Pubmed | Neto1 is an auxiliary subunit of native synaptic kainate receptors. | 3.79e-06 | 6 | 18 | 2 | 21734292 | |
| Pubmed | 5.30e-06 | 7 | 18 | 2 | 17428973 | ||
| Pubmed | Glutamate receptors in cortical plasticity: molecular and cellular biology. | 5.30e-06 | 7 | 18 | 2 | 9016303 | |
| Pubmed | 5.30e-06 | 7 | 18 | 2 | 19342380 | ||
| Pubmed | Glutamate receptors: brain function and signal transduction. | 5.30e-06 | 7 | 18 | 2 | 9651535 | |
| Pubmed | 5.30e-06 | 7 | 18 | 2 | 1310861 | ||
| Pubmed | Transmembrane topology of the glutamate receptor subunit GluR6. | 7.07e-06 | 8 | 18 | 2 | 8163463 | |
| Pubmed | 9.09e-06 | 9 | 18 | 2 | 34100982 | ||
| Pubmed | Expression of glutamate receptor subunit genes during development of the mouse retina. | 9.09e-06 | 9 | 18 | 2 | 9051806 | |
| Pubmed | 1.66e-05 | 12 | 18 | 2 | 11891216 | ||
| Pubmed | Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol. | 1.97e-05 | 13 | 18 | 2 | 20859245 | |
| Pubmed | 3.85e-05 | 18 | 18 | 2 | 10827173 | ||
| Pubmed | 3.85e-05 | 18 | 18 | 2 | 16247769 | ||
| Pubmed | 6.36e-05 | 23 | 18 | 2 | 8464923 | ||
| Pubmed | Glutamate can act as a signaling molecule in mouse preimplantation embryos†. | 6.94e-05 | 24 | 18 | 2 | 35746896 | |
| Pubmed | 6.94e-05 | 24 | 18 | 2 | 22534482 | ||
| Pubmed | A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome. | 1.54e-04 | 205 | 18 | 3 | 12040188 | |
| Interaction | GRIK4 interactions | 2.10e-05 | 8 | 18 | 2 | int:GRIK4 | |
| Interaction | GRIK3 interactions | 3.38e-05 | 10 | 18 | 2 | int:GRIK3 | |
| Interaction | LRP8 interactions | 5.85e-05 | 86 | 18 | 3 | int:LRP8 | |
| Interaction | GRIK5 interactions | 1.42e-04 | 20 | 18 | 2 | int:GRIK5 | |
| Cytoband | 2p15 | 6.71e-05 | 31 | 18 | 2 | 2p15 | |
| Cytoband | 4q32.3 | 8.08e-05 | 34 | 18 | 2 | 4q32.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p15 | 1.36e-04 | 44 | 18 | 2 | chr2p15 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q32 | 1.01e-03 | 120 | 18 | 2 | chr4q32 | |
| GeneFamily | Glutamate ionotropic receptor kainate type subunits | 4.03e-06 | 5 | 12 | 2 | 1199 | |
| GeneFamily | Carboxypeptidases | 8.42e-05 | 21 | 12 | 2 | 1321 | |
| GeneFamily | Ubiquitin specific peptidases | 6.10e-04 | 56 | 12 | 2 | 366 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.66e-05 | 163 | 18 | 3 | 51dee6c21cbeca4e17d1cc386e203f0c403089e8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.80e-05 | 165 | 18 | 3 | e2aebb2fe197151e019371b8960f76f0c2386f08 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.80e-05 | 165 | 18 | 3 | b087771499aeb31cc4a338d2d0a9392a4ec1ac45 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.80e-05 | 165 | 18 | 3 | d8f8b088fd28a6b9dbd6b51bcaee42000e963321 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.08e-05 | 169 | 18 | 3 | 96a2aec9acf8a6f966973c035e5ade456cf47772 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.92e-05 | 180 | 18 | 3 | af2bafcd1b2082629de3ea336711add01565c4c4 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.92e-05 | 180 | 18 | 3 | f29a995cf6e1a1836ed68b73258d9370bf3d4434 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.16e-05 | 183 | 18 | 3 | 8820cfed27b292bc0bc9cde4005219ed41900552 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.25e-05 | 184 | 18 | 3 | 30ca56d64c961127e26122613e35aa2b46fde2df | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.42e-05 | 186 | 18 | 3 | ea936e66ae4b7b40564711fad60ac0137327995f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.42e-05 | 186 | 18 | 3 | d8d559daff4aeef334d403fde4e3ee2e4a6086d0 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.51e-05 | 187 | 18 | 3 | a0bd2b0ec9e73521c245037b1dd51ff8cf24cbf5 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.51e-05 | 187 | 18 | 3 | f2af79a20438108c814a73f9e24cd986d537237f | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.59e-05 | 188 | 18 | 3 | 8385fd384fc55e3b17802bb6698eb93b2c16d7f2 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.59e-05 | 188 | 18 | 3 | cb9d0b48e2fd9cc576132803273b9c0382900944 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-05 | 190 | 18 | 3 | ff3dec5b45c6ea9b5319fb51a0198c6773b7be26 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.77e-05 | 190 | 18 | 3 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-05 | 190 | 18 | 3 | e2481bd5166fde2cdc0c3824894f2bccb8294fdd | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-05 | 190 | 18 | 3 | 4971857eac9af17d66d673ed2ab7072639f60a10 | |
| ToppCell | 368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 6.14e-05 | 194 | 18 | 3 | 58046894446cb250814252a23f60fdd59c114d77 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.43e-05 | 197 | 18 | 3 | 470e23dee4ca35e1fd021b7cdd58fcbc90639837 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_systemic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.52e-05 | 198 | 18 | 3 | 882710bd6215e299257dd3df234292db9a2823ba | |
| ToppCell | mild-Neutrophil|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.62e-05 | 199 | 18 | 3 | 2fd5759acf49c02c5bbcc2941676216e7444d76d | |
| ToppCell | mild-Neutrophil|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.62e-05 | 199 | 18 | 3 | ca319976a7d2576186d0a98cdc93e4c2d5fe8a05 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.88e-04 | 97 | 18 | 2 | 16947da747504c2edb9f2e7ee6f05babda0fae60 | |
| ToppCell | facs-Thymus-Epithelium-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.83e-04 | 110 | 18 | 2 | 3a641dced828ed97a8eea70d0a7b76f33630c9be | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Myeloid|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.98e-04 | 117 | 18 | 2 | f0c738b6b850733f9af68704172554177a1c1198 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Myeloid-Megakaryocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.98e-04 | 117 | 18 | 2 | b5cb9d69ddd42331134f7e4bd51bd1c31030893c | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-03 | 123 | 18 | 2 | 87401764a073c1808f214642a9c84299c78f7ec7 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Pax6|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.23e-03 | 130 | 18 | 2 | 60e28d452d0e2af768459ba8dbe998117c94a251 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Krt73|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.25e-03 | 131 | 18 | 2 | 9ca209a8652aae603c4a867ea06b06ac51e7d189 | |
| ToppCell | Severe-B_intermediate-14|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.46e-03 | 142 | 18 | 2 | f9cbc266fcea19bec504be4f3a28d1173c6b2e3c | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c03-MKI67|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.55e-03 | 146 | 18 | 2 | c0e1836845c083bf9d88a620da27acbfdea9fb20 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-hematologic-hematopoietic_progenitor-hematopoietic_stem_cell|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.61e-03 | 149 | 18 | 2 | e99b7cd3728ce76b365526734c2e7f845b2e62c8 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-hematologic-hematopoietic_progenitor|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.61e-03 | 149 | 18 | 2 | 6a28dd4530ed411747fdfe743db138a1b5547ed7 | |
| ToppCell | E16.5-samps-Myeloid-Fetal_macrophage-macrophage_-_intermediate_-_unactivated|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.63e-03 | 150 | 18 | 2 | 60fdd266aaca1b589b9a77465a4a7fad4921339a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-03 | 150 | 18 | 2 | 8645b9c7f9511ed6cc9afe04440c2873a3094150 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Granulocytic-Mast|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.65e-03 | 151 | 18 | 2 | 9702575e47ececcf0a9f0f20a4a920dbb1ba5657 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Granulocytic-Mast-Mast_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.65e-03 | 151 | 18 | 2 | 673e4ab117b723c14d1df3804bbedc9e48284a9d | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD8+_T_naive|World / disease group, cell group and cell class (v2) | 1.67e-03 | 152 | 18 | 2 | f944743f40ff6ed3a7a096dd53e12d3526c67c4d | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.67e-03 | 152 | 18 | 2 | 8ff5a178a8f3550d89a003c0858820aab3773386 | |
| ToppCell | E16.5-samps-Myeloid-Fetal_macrophage|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.70e-03 | 153 | 18 | 2 | e9567966fe4426176e2f2dc0be4832c769c9903a | |
| ToppCell | PBMC-Control-cDC_2|Control / Compartment, Disease Groups and Clusters | 1.70e-03 | 153 | 18 | 2 | 4ee37266b0054f276c7a73ab9220f681b9d74c71 | |
| ToppCell | Adult-Immune-mast_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.74e-03 | 155 | 18 | 2 | 7c9de0591d1bf756b8e268b278bbe10bd5415dcd | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.76e-03 | 156 | 18 | 2 | 6365b69ede98bc866e996bc52736b00401aacf6f | |
| ToppCell | 5'-Adult-Appendix-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.76e-03 | 156 | 18 | 2 | 58b9520fce6e259b36c3d59e82b712f5e7729e3e | |
| ToppCell | facs-Aorta-Heart-18m-Mesenchymal-fibrocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-03 | 156 | 18 | 2 | 5b56217336771baf57d791efcb4e206c6aea83b1 | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.76e-03 | 156 | 18 | 2 | 8353f98e7d393d4299ed1da8f66cfbc7176df1b5 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c08-GZMK-FOS_h|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.76e-03 | 156 | 18 | 2 | 14e2f693a75f1075f40cc7b16ee430262a5de016 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-03 | 156 | 18 | 2 | 28c4fb4d2c6c47696c3a6722998f9da5a8923323 | |
| ToppCell | E16.5-samps-Myeloid|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.76e-03 | 156 | 18 | 2 | c7c73cef5700b0ae75280e62c94728434c712537 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-gliogenic/outer_RGCs_and_astrocytes|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.78e-03 | 157 | 18 | 2 | 2c1219ee19a6246a3b9f5c2c1a37f26ea934a822 | |
| ToppCell | E15.5-Hematopoietic-Immune-immune_cell_unspecified|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.78e-03 | 157 | 18 | 2 | 4263627911657e788a1d0230690ee434e8a4f9a1 | |
| ToppCell | E12.5-Hematopoietic|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.78e-03 | 157 | 18 | 2 | 344351c7534440532c6cd4a95782ac90b10d45f3 | |
| ToppCell | E15.5-Hematopoietic-Immune|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.78e-03 | 157 | 18 | 2 | de689a133863ed74d848eba0a4f392357ac28245 | |
| ToppCell | E15.5-Hematopoietic|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.78e-03 | 157 | 18 | 2 | 6315aef4b9bf673069d43a730d4e940011509ac1 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.78e-03 | 157 | 18 | 2 | 516903469756c5fabfdf56d7bd59b3bdd7b44e39 | |
| ToppCell | COVID_non-vent-Myeloid-Monocytic-SC_&_Eosinophil|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.81e-03 | 158 | 18 | 2 | 0d4fe87fc7901dd5f9c004e91708a03cafdb4ad9 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-24m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-03 | 158 | 18 | 2 | f41ee21e5888359d817be1e3a902c132cb68e350 | |
| ToppCell | droplet-Bladder-nan-24m-Hematologic-macrophage|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-03 | 158 | 18 | 2 | 4a9d4706876f6e86fc5d63ad6dc7df1b4a5cfd9e | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.81e-03 | 158 | 18 | 2 | f61ebe3a316e4259387cd9da83707f15e6473cae | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.81e-03 | 158 | 18 | 2 | c736834269c89e003c61a62b63e4e50dbf0e1538 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-24m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-03 | 158 | 18 | 2 | d689feb7f612aef170da76fcf14abf2dd589082b | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-24m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-03 | 158 | 18 | 2 | 829ff3df46f173f2ff1c435e9bce35425e603b42 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-03 | 159 | 18 | 2 | 5ca96db4281abb5f646150ccf36adc66ab201c78 | |
| ToppCell | E17.5-Hematopoietic|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.83e-03 | 159 | 18 | 2 | a5648f731f1a22d1af1be2b0e1b80e29d05bae04 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.83e-03 | 159 | 18 | 2 | fb9a45c1d596226128ce4f1adaebb066766e590a | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-03 | 160 | 18 | 2 | 18954241e11309ecb0f3ca87897eadcb20dc8eca | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-03 | 160 | 18 | 2 | 8624f101828efd32cdd38a65df8d94d690720a63 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-03 | 160 | 18 | 2 | 9de3dd6b9d4b51314d60b3b01f4132bcfa2dfc18 | |
| ToppCell | E12.5-Hematopoietic-Immune|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.85e-03 | 160 | 18 | 2 | cd59830a524c14a1f591c5c615b55510e4104e5b | |
| ToppCell | E12.5-Hematopoietic-Immune-immune_cell_unspecified|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.85e-03 | 160 | 18 | 2 | 5a4a5a50dfdf6af9406e4f685712f7fe390a02f3 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Myeloid|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-03 | 161 | 18 | 2 | 3db97af49520dc8cbafb4454d8afd9d588160e89 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.88e-03 | 161 | 18 | 2 | 52556b89808e551540f33a13f57417a6696c2438 | |
| ToppCell | Adult-Immune-mast_cell|Adult / Lineage, Cell type, age group and donor | 1.88e-03 | 161 | 18 | 2 | 44f5c0256b3ce264a6c7b62740f32dcd45ee052d | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 1.88e-03 | 161 | 18 | 2 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | E17.5-Hematopoietic-Immune|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.88e-03 | 161 | 18 | 2 | e3ff08d0b9c686253556c56ee88648206751ef2b | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Myeloid-macrophage|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-03 | 161 | 18 | 2 | f1d258c81bcf0f3c52bd20aa58faa9a5fd888168 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.88e-03 | 161 | 18 | 2 | 54f156cf2bd5a6ba9a78ec4e3ee28b89998aec2e | |
| ToppCell | PND01-Immune-Immune_Myeloid-Megakaryocyte/Platelet|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.88e-03 | 161 | 18 | 2 | 242891be849a4398fe8bea44875ae1ba57950944 | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-03 | 161 | 18 | 2 | a7e74bc80ac11250e353e5614b19c05793fc2e95 | |
| ToppCell | E17.5-Hematopoietic-Immune-immune_cell_unspecified|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.88e-03 | 161 | 18 | 2 | 30741ca6548db2dfb5cf1faecf0d7412c91d0077 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-03 | 161 | 18 | 2 | 1b805f77790aeb8a71b08bfac2fe2eed7343258f | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Myeloid-macrophage|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-03 | 161 | 18 | 2 | 787f91f906756ef570c0d02936c3cdfafb3f7454 | |
| ToppCell | 5'-Adult-Appendix-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.90e-03 | 162 | 18 | 2 | ded08da888d8c481f0f96d1e0bfd03d617966910 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Myeloid-macrophage|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-03 | 162 | 18 | 2 | db1e09324e9fdd5e571600cff4f2b1c0cb3c179d | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Myeloid-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-03 | 162 | 18 | 2 | 9734943c8b7c04e568792253b7352672a3a5cc58 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Myeloid|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-03 | 162 | 18 | 2 | 48d7bee271f74b5d06c03c6ae06a662d765a6de3 | |
| ToppCell | E12.5-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.92e-03 | 163 | 18 | 2 | c21114826bee1b05b411984326fef6b6e0d05316 | |
| ToppCell | facs-MAT-Fat-3m-Myeloid-myeloid_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-03 | 163 | 18 | 2 | 5fc836444bc156c8248abee001b0ecbe43f980c9 | |
| ToppCell | droplet-Spleen-nan-18m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-03 | 163 | 18 | 2 | bc37c5d9f48b16096d5313657563f3ec84028c8c | |
| ToppCell | 368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.92e-03 | 163 | 18 | 2 | 4b8abbad4df040c895e3afb240759ebbc66b4d0e | |
| ToppCell | E12.5-Endothelial-lymphatic_endothelial_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.92e-03 | 163 | 18 | 2 | 5d49414432db259a19df50d7944581d00b69f537 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.92e-03 | 163 | 18 | 2 | 8d17f44faf0549fe71a9a45f811f50d767275414 | |
| ToppCell | droplet-Fat-Mat-18m-Myeloid-myeloid_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-03 | 164 | 18 | 2 | baf6c40b004433c6b1d0bbbb74f73fcd6ee162ea | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-03 | 164 | 18 | 2 | 43630a448f4369fa9e4e3eccdf3b9f29cec16c39 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-03 | 164 | 18 | 2 | 54f8f11d2fa899005530c08e7a1ee728c7b0799c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-03 | 164 | 18 | 2 | 108fbecb56d69a675d6ce6e826a873ae528f2fd7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-03 | 164 | 18 | 2 | f6a961fa2002da7d9679f32af99e1314c0593ef9 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.94e-03 | 164 | 18 | 2 | 3caf4cdaa0164907893fea61e251fd8b5fa926e4 | |
| Drug | 5-nitro-6,7,8,9-tetrahydrobenzo(G)indole-2,3-dione-3-oxime | 5.90e-07 | 2 | 18 | 2 | ctd:C084273 | |
| Drug | bromoacetyl-D-arginine | 1.65e-05 | 8 | 18 | 2 | CID003082329 | |
| Drug | 1m5b | 2.12e-05 | 9 | 18 | 2 | CID000447081 | |
| Drug | LY339434 | 2.12e-05 | 9 | 18 | 2 | CID006324635 | |
| Drug | Benzoates | 2.65e-05 | 10 | 18 | 2 | ctd:D001565 | |
| Drug | C6E3 | 3.93e-05 | 85 | 18 | 3 | CID000094362 | |
| Drug | decahydroisoquinoline | 7.04e-05 | 16 | 18 | 2 | CID000097812 | |
| Disease | Schizophrenia | 1.47e-04 | 883 | 18 | 5 | C0036341 | |
| Disease | calcium measurement | 4.90e-04 | 628 | 18 | 4 | EFO_0004838 | |
| Disease | temporal horn of lateral ventricle volume measurement | 8.76e-04 | 72 | 18 | 2 | EFO_0010333 | |
| Disease | Left-Sided Heart Failure | 2.03e-03 | 110 | 18 | 2 | C0023212 | |
| Disease | Myocardial Failure | 2.03e-03 | 110 | 18 | 2 | C1959583 | |
| Disease | Heart Failure, Right-Sided | 2.03e-03 | 110 | 18 | 2 | C0235527 | |
| Disease | Congestive heart failure | 2.03e-03 | 110 | 18 | 2 | C0018802 | |
| Disease | Heart failure | 2.03e-03 | 110 | 18 | 2 | C0018801 | |
| Disease | Heart Decompensation | 2.03e-03 | 110 | 18 | 2 | C1961112 | |
| Disease | coronary artery calcification | 2.42e-03 | 450 | 18 | 3 | EFO_0004723 | |
| Disease | Bipolar Disorder | 2.86e-03 | 477 | 18 | 3 | C0005586 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 3.48e-03 | 145 | 18 | 2 | DOID:1289 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QEEGKLHMMKEKWWR | 801 | P39086 | |
| EMKMWEEKIAQMRWE | 1741 | Q96MT7 | |
| MIDWIKKMWHIYTME | 1216 | O00370 | |
| LWMSSKWLSMNVLML | 351 | P50440 | |
| HWAEDMKPLLQMKKW | 336 | Q8IY21 | |
| MYPKLCQHWQVIWMM | 836 | Q9Y6F6 | |
| NWEKIVAWTEKMMDK | 121 | P15088 | |
| QMDKMHKKATKWMNW | 346 | Q86Z20 | |
| EELMEWWKMMSETLN | 461 | P16870 | |
| KKEWTWDESKMLVMQ | 96 | O75052 | |
| QEEGKLHMMKEKWWR | 786 | Q13002 | |
| LGWWEKNEMNMVMSL | 401 | Q8TDI8 | |
| LWWVSSIMMLHMKYS | 56 | Q86X19 | |
| IWSATNMKWIEAKMK | 181 | Q8WVY7 | |
| HWITMWAEKELNMMK | 941 | Q70CQ2 | |
| EMTWNNMEKKEKLMW | 516 | P17480 | |
| WYMKMMWAWLQAKRK | 616 | O60603 | |
| MTRTSKWMEMLGEWE | 71 | P35125 | |
| YLMWRNWQHKNMKSM | 816 | P98155 |